𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Considerations for the Design of Future Clinical Trials in Metastatic Renal Cell Carcinoma

✍ Scribed by Escudier, Bernard; Heng, Daniel Y.C.; Smyth-Medina, Arthur; Porta, Camillo

Book ID
122529517
Publisher
CIG Media Group, LP.
Year
2014
Tongue
English
Weight
523 KB
Volume
12
Category
Article
ISSN
1558-7673

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Stage migration and increasing proportio
Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients : Implications for clinical trial design and interpretation
✍ Sujata Patil; Nicole Ishill; John Deluca; Robert J. Motzer πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 195 KB

## Abstract ## BACKGROUND: The Memorial Sloan‐Kettering Cancer Center risk model classifies patients with metastatic renal cell carcinoma (RCC) by 5 pretreatment features as favorable, intermediate, and poor risk. The number of Memorial Sloan‐Kettering Cancer Center patients in each risk group was